The proposed Conte Center for the Neurosciences of Mental Disorders in Schizophrenia Research integrates the efforts of clinical, basic, and statistical scientists in a common effort to evaluate the hypothesis that schizophrenia is associated with an imbalance in dopamine functions. The Biostatistics and Data Management Core (BDMC) constitutes a resource for investigators seeking advice and technical support for data collection, study design, statistical analysis, and analytic interpretation at all stages of the research process. The data that will be collected by Center investigators come from a wide range of sources. The variety and volume of data represent enormous potential for the Center, but also underscore the importance of proper data management and statistical analysis to achieve the Center's aims.
The specific aims for the Biostatistics Resource within the BDMC are: 1) To provide intensive, coordinated input into the design, conduct, and analysis of Center studies; 2) To assist Center members in the pursuit of independent research funding; 3) To participate in the review of publication/presentation materials that derive from analyses of the Center database; 4) To oversee and coordinate the activities of statisticians and data analysts in providing day-to- day support for analysis. The:
aims of the Data Management Resource wiithin the BDMC are: 1):To serve as the central conduit through which the data from the various cores and projects are integrated; 2)To maintain and expand the Center's existing database containing pre-clinical, clinical, and brain imaging data; 3 ) To provide coordinated lassistance with database planning and programming and data entr;; 4) To prepare an exportable data archive suitable for distribution to investigators both within and outside of Columbia/NYSPI. A Core devoted to biostatistics and data management will enhance the process of data collection and analysis, allowing all co-investigators to be more fully productive in fulfilling the substantive research aims put forth by each Core and Project.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH066171-05
Application #
7643277
Study Section
Special Emphasis Panel (ZMH1)
Project Start
Project End
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
5
Fiscal Year
2008
Total Cost
$145,579
Indirect Cost
Name
New York State Psychiatric Institute
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Slifstein, Mark; van de Giessen, Elsmarieke; Van Snellenberg, Jared et al. (2015) Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatry 72:316-24
Chuhma, Nao; Mingote, Susana; Moore, Holly et al. (2014) Dopamine neurons control striatal cholinergic neurons via regionally heterogeneous dopamine and glutamate signaling. Neuron 81:901-12
Poels, E M P; Kegeles, L S; Kantrowitz, J T et al. (2014) Imaging glutamate in schizophrenia: review of findings and implications for drug discovery. Mol Psychiatry 19:20-9
Poels, Eline M P; Kegeles, Lawrence S; Kantrowitz, Joshua T et al. (2014) Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings. Schizophr Res 152:325-32
Poels, Eline M P; Girgis, Ragy R; Thompson, Judy L et al. (2013) In vivo binding of the dopamine-1 receptor PET tracers [¹¹C]NNC112 and [¹¹C]SCH23390: a comparison study in individuals with schizophrenia. Psychopharmacology (Berl) 228:167-74
Kisby, Glen E; Moore, Holly; Spencer, Peter S (2013) Animal models of brain maldevelopment induced by cycad plant genotoxins. Birth Defects Res C Embryo Today 99:247-55
Mihali, Andra; Subramani, Shreya; Kaunitz, Genevieve et al. (2012) Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery. Expert Rev Neurother 12:785-99
Ward, Ryan D; Simpson, Eleanor H; Richards, Vanessa L et al. (2012) Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia. Neuropsychopharmacology 37:1699-707
Abi-Dargham, Anissa; Xu, Xiaoyan; Thompson, Judy L et al. (2012) Increased prefrontal cortical D? receptors in drug naive patients with schizophrenia: a PET study with [¹¹C]NNC112. J Psychopharmacol 26:794-805
Li, Yan-Chun; Kellendonk, Christoph; Simpson, Eleanor H et al. (2011) D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex. Proc Natl Acad Sci U S A 108:12107-12

Showing the most recent 10 out of 31 publications